Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Transurban (TCL.AX)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date Stock Price (A$) Price Target (A$) Rating
2022-04-0113.4914.90Buy
2022-06-2113.9515.35Buy
2022-10-2112.3415.20Buy
2023-02-0814.0615.45Buy
2023-08-1713.1815.35Buy
2023-10-2011.9714.50Buy
2024-02-0213.4114.80Buy
2024-07-1712.9714.60Buy
2024-10-2313.0514.55Buy
2024-12-1113.0014.75Buy
2025-02-2113.1514.85Buy
2025-04-1713.8614.60Neutral

Disclosures

  • Within the past 12 months, UBS has received compensation for investment banking services from this company/entity or one of its affiliates.
  • UBS expects to receive or intend to seek compensation for investment banking services from this company/entity within the next three months.
  • Within the past 12 months, UBS has received compensation for products and services other than investment banking services from this company/entity.
Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.